These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6602205)

  • 1. In vitro generation of cytotoxic cells specific for human minor histocompatibility antigens by lymphocytes from a normal donor potentially primed during pregnancy.
    Tekolf WA; Shaw S
    J Exp Med; 1983 Jun; 157(6):2172-7. PubMed ID: 6602205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro.
    Sondel PM; Hank JA; Wendel T; Flynn B; Bozdech MJ
    J Clin Invest; 1983 Jun; 71(6):1779-86. PubMed ID: 6223050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
    Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary in vitro generation of cytotoxic cells specific for human minor histocompatibility antigens between HLA-identical siblings.
    Tekolf WA; Shaw S
    J Immunol; 1984 Apr; 132(4):1756-60. PubMed ID: 6199410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy can induce priming of cytotoxic T lymphocytes specific for paternal HLA antigens that is associated with antibody formation.
    Bouma GJ; van Caubergh P; van Bree SP; Castelli-Visser RM; Witvliet MD; van der Meer-Prins EM; van Rood JJ; Claas FH
    Transplantation; 1996 Sep; 62(5):672-8. PubMed ID: 8830835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.
    Faber LM; van der Hoeven J; Goulmy E; Hooftman-den Otter AL; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
    J Clin Invest; 1995 Aug; 96(2):877-83. PubMed ID: 7635982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the major histocompatibility antigens HLA-A2 and HLA-B7 by DNA-mediated gene transfer.
    Bernabeu C; Finlay D; van de Rijn M; Maziarz RT; Biro PA; Spits H; de Vries J; Terhorst CP
    J Immunol; 1983 Oct; 131(4):2032-7. PubMed ID: 6352810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
    Yannelli JR; Moore LC; Engelhard VH
    J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minor histocompatibility antigen-specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells.
    Marijt WA; Veenhof WF; Brand A; Goulmy E; Fibbe WE; Willemze R; van Rood JJ; Falkenburg JH
    J Exp Med; 1991 Jan; 173(1):101-9. PubMed ID: 1985117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-nonself discrimination and repertoire selection of human T cells differentiated in an HLA-semiallogeneic environment following bone marrow transplantation for severe combined immunodeficiency.
    Knobloch C; Goldmann SF; Friedrich W
    Eur J Immunol; 1991 Oct; 21(10):2479-87. PubMed ID: 1833204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel minor histocompatibility antigen recognized by HLA-A31 restricted cytotoxic T lymphocytes generated from HLA-identical bone marrow donor lymphocytes.
    Yazaki M; Takahashi T; Andho M; Akatsuka Y; Ito T; Miyake Y; Ito Y; Nakamura S; Wada Y
    Bone Marrow Transplant; 1999 Jul; 24(2):129-37. PubMed ID: 10455340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens.
    de Bueger M; Bakker A; Van Rood JJ; Van der Woude F; Goulmy E
    J Immunol; 1992 Sep; 149(5):1788-94. PubMed ID: 1380540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.
    Falkenburg JH; Goselink HM; van der Harst D; van Luxemburg-Heijs SA; Kooy-Winkelaar YM; Faber LM; de Kroon J; Brand A; Fibbe WE; Willemze R
    J Exp Med; 1991 Jul; 174(1):27-33. PubMed ID: 2056279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-restricted cytotoxicity against male-specific (H-Y) antigen after acute rejection of an HLA-identical sibling kidney: clonal distribution of the cytotoxic cells.
    Pfeffer PF; Thorsby E
    Transplantation; 1982 Jan; 33(1):52-6. PubMed ID: 6461110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential behavior of cytotoxic effector cells against HLA antigens in strong genetic linkage disequilibrium.
    Kim SJ; Christiansen FT; Silver DM; Dupont B
    Immunogenetics; 1981; 13(4):297-309. PubMed ID: 6168580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-specific decreased cell-mediated cytotoxicity in recipients of well functioning, one HLA haplotype-mismatched kidney allografts.
    Pfeffer PF; Thorsby E; Hirschberg H
    Transplantation; 1983 Feb; 35(2):156-60. PubMed ID: 6187111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mismatches for two major and one minor histocompatibility antigen correlate with a patient's rejection of a bone marrow graft from a serologically HLA-identical sibling.
    Lienert-Weidenbach K; Valiante NM; Brown C; White C; Johnston-Dow L; McGinnis M; Krausa P; Lakes DM; Wolf JL; Blume KG; Parham P
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):255-60. PubMed ID: 9450920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell responses to minor histocompatibility antigens.
    Lai PK; Waterfield JD; Gascoigne NR; Sharrock CE; Mitchison NA
    Immunology; 1982 Oct; 47(2):371-81. PubMed ID: 6214502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.